alpha-Fetoprotein/AFP Antibody (189502) [Unconjugated]

Western blot shows lysates of HepG2 human hepatocellular carcinoma cell line. PVDF membrane was probed with 0.5 µg/mL of Mouse Anti-Human/Mouse alpha ‑Fetoprotein/AFP Monoclonal Antibody (Catalog # MAB1368) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for alpha ‑Fetoprotein/AFP at approximately 70 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

alpha ‑Fetoprotein/AFP was detected in immersion fixed HepG2 human hepatocellular carcinoma cell line using Mouse Anti-Human/Mouse alpha ‑Fetoprotein/AFP Monoclonal Antibody (Catalog # MAB1368) at 25 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

HepG2 human hepatocellular carcinoma cell line was stained with Mouse Anti-Human/Mouse alpha ‑Fetoprotein/AFP Monoclonal Antibody (Catalog # MAB1368, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0102B). To facilitate intracellular staining, cells were fixed with Flow Cytometry Fixation Buffer (Catalog # FC004) and permeabilized with Flow Cytometry Permeabilization/Wash Buffer I (Catalog # FC005). View our protocol for Staining Intracellular Molecules.

Simple Western lane view shows lysates of HepG2 human hepatocellular carcinoma cell line, loaded at 0.2 mg/mL. A specific band was detected for alpha ‑Fetoprotein/AFP at approximately 70 kDa (as indicated) using 5 µg/mL of Mouse Anti-Human/Mouse alpha ‑Fetoprotein/AFP Monoclonal Antibody (Catalog # MAB1368). This experiment was conducted under reducing conditions and using the12-230 kDa separation system.

Western blot shows lysates of HepG2 human hepatocellular carcinoma parental cell line and alpha ‑Fetoprotein/AFP knockout HepG2 cell line (KO). PVDF membrane was probed with 0.1 µg/mL of Mouse Anti-Human/Mouse alpha ‑Fetoprotein/AFP Monoclonal Antibody (Catalog # MAB1368) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for alpha ‑Fetoprotein/AFP at approximately 70 kDa (as indicated) in the parental HeLacell line, but is not detectable in knockout HeLa cell line. GAPDH(Catalog # AF5718) is shown as a loading control. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

alpha -Fetoprotein/AFP knockout HepG2 hepatocellular carcinoma cell line was stained with Mouse Anti-Human alpha -Fetoprotein/AFP Monoclonal Antibody (Catalog # MAB1368, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram) followed by PE-conjugated Goat anti-Mouse IgG Secondary Antibody (Catalog # F0102B). No staining in the alpha -Fetoprotein/AFP knockout HepG2 cell line was observed. View our protocol for Staining Membrane-associated Proteins.

• Reactivity: Hu, Mu
• Applications: WB, Simple Western, CyTOF-ready, Flow, ICC/IF, KO
• Clone: 189502
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated
• Concentration: LYOPH

alpha-Fetoprotein/AFP Antibody (189502) [Unconjugated] Summary

• Immunogen: Human umbilical cord serum-derived alpha ‑Fetoprotein/AFP
• Specificity: Detects human alpha ‑Fetoprotein/AFP in direct ELISAs and Western blots.
• Source: N/A
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Gene: AFP
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • CyTOF-ready
  • Immunocytochemistry 8-25 ug/mL
  • Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells
  • Knockout Validated
  • Simple Western 5 ug/mL
  • Western Blot 0.5 ug/mL
• Application Notes: In Simple Western only 10-15 uL of the recommended dilution is used per data point.

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
• Preservative: No Preservative
• Concentration: LYOPH
• Reconstitution Instructions: Reconstitute at 0.5 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for alpha-Fetoprotein/AFP Antibody (189502) [Unconjugated]

• AFP
• Alpha-1-fetoprotein
• alpha-fetoglobulin
• alpha-Fetoprotein
• DSCAM2
• FETA
• HP
• HPAFP

Background

alpha -Fetoprotein is a major plasma protein in the fetus. Its concentration is normally low in the adult except when produced by certain tumors. AFP is produced by the yolk sac and the liver during fetal development. It is thought to be the fetal form of serum albumin. AFP binds to copper, nickel, fatty acids and billirubin and can found in mono-, di or trimeric forms.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for alpha-Fetoprotein/AFP Antibody (MAB1368)(57)

Publications using MAB1368

• Li, C;Han, X;Wang, J;Liu, F;Zhang, Y;Li, Z;Lu, Z;Yue, Y;Xiang, J;Li, X; Mixed-Lineage Leukemia 1 Inhibition Enhances the Differentiation Potential of Bovine Embryonic Stem Cells by Increasing H3K4 Mono-Methylation at Active Promoters International journal of molecular sciences 2023-07-25 [PMID: 37569280] (IHC, Bovine)
• S Merkert, A Haase, J Dahlmann, G Göhring, FH Waqas, F Pessler, U Martin, R Olmer Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing Stem Cell Research, 2023-04-01;69(0):103090. 2023-04-01 [PMID: 37104932] (ICC, Human)
• L Li, X Si, J Yang, M Lei, H Liu, J Ruan, H Fu, W Li, H Yang, X Lei, H Sang Generation of a human iPSC line (CIBi014-A) from a patient with Parkinson's disease carrying a novel heterozygotic PARK8 (LRRK2) mutation Stem Cell Research, 2022-12-09;66(0):102995. 2022-12-09 [PMID: 36528012] (ICC, Human)
• Z Jiang, XJ Gu, WM Su, QQ Duan, JY Lin, B Cao, HF Shang, YP Chen Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation Stem Cell Research, 2022-08-04;64(0):102881. 2022-08-04 [PMID: 35944313] (Flow Cytometry, ICC, Human)
• BK Wu, SC Mei, EH Chen, Y Zheng, D Pan YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis Nature Genetics, 2022-07-14;0(0):. 2022-07-14 [PMID: 35835915] (IHC, Mouse)
• AJ Fortune, BV Taylor, JC Charleswor, KP Burdon, NB Blackburn, JL Fletcher, A Mehta, KM Young Generation and characterisation of four multiple sclerosis iPSC lines from a single family Oncogene, 2022-06-05;62(0):102828. 2022-06-05 [PMID: 35679759] (ICC, Human)
• Y Shimoda, N Murakoshi, H Mori, D Xu, K Tajiri, Y Hemmi, I Sato, M Noguchi, Y Nakamura, Y Hayashi, M Ieda Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation Stem Cell Research, 2022-04-27;62(0):102793. 2022-04-27 [PMID: 35500377] (ICC, Human)
• Y Luo, Y Chen, M Zhang, X Ma, D Zhu, Y Chen Generation of an induced pluripotent stem cell line GZHMCi008-A derived from a patient with SRY-positive 46,XX testicular disorder of sex development Stem Cell Research, 2021-10-22;57(0):102583. 2021-10-22 [PMID: 34710837] (Flow Cytometry, ICC, Human)
• A Mehta, P Lu, BV Taylor, J Charleswor, AL Cook, KP Burdon, AW Hewitt, KM Young Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis Stem Cell Research, 2021-10-12;57(0):102568. 2021-10-12 [PMID: 34678664] (Flow Cytometry, ICC, Human)
• A Cañibano-H, L Valdes-San, AB Garcia-Del, B Ponte-Zúñi, FJ Diaz-Corra, B de la Cerd Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene Stem Cell Research, 2021-03-18;53(0):102301. 2021-03-18 [PMID: 33773389] (Flow Cytometry, ICC, Human)
• A Haase, T Kohrn, V Fricke, ME Ricci Sign, M Witte, G Göhring, I Gruh, U Martin Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives Stem Cell Research, 2021-01-30;52(0):102206. 2021-01-30 [PMID: 33571874] (Flow Cytometry, ICC, Human)
• J Geuder, LE Wange, A Janjic, J Radmer, P Janssen, JW Bagnoli, S Müller, A Kaul, M Ohnuki, W Enard A non-invasive method to generate induced pluripotent stem cells from primate urine Scientific Reports, 2021-02-10;11(1):3516. 2021-02-10 [PMID: 33568724] (ICC, Human)
• S Merkert, MC Jaboreck, L Engels, MNH Malik, G Göhring, F Pessler, U Martin, R Olmer Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing Stem Cell Research, 2020-12-22;50(0):102135. 2020-12-22 [PMID: 33383405] (Flow Cytometry, Human)
• L Jin, Y Chen, DK Crossman, A Datta, T Vu, JA Mobley, MK Basu, M Scarduzio, H Wang, C Chang, PK Datta STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells Nat Commun, 2020-11-23;11(1):5941. 2020-11-23 [PMID: 33230114] (IHC, Mouse)
• YP Li, H Liu, ZB Jin Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation Stem Cell Res, 2020-11-03;49(0):102075. 2020-11-03 [PMID: 33207307] (ICC, Human)
• MA Jamil, H Singer, R Al-Rifai, N Nüsgen, M Rath, S Strauss, I Andreou, J Oldenburg, O El-Maarri Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells Int J Mol Sci, 2020-10-21;21(20):. 2020-10-21 [PMID: 33096636] (ICC, Human)
• M Kamand, M Ilieva, S Louise For, M Thomassen, M Meyer, Å Fex Svenni, T Maria Mich Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome Stem Cell Res, 2020-09-01;48(0):101974. 2020-09-01 [PMID: 32916638] (ICC, Human)
• VS Ovechkina, MA Maretina, AA Egorova, VS Baranov, AV Kiselev, SM Zakian, KR Valetdinov Generation of a spinal muscular atrophy type III patient-specific induced pluripotent stem cell line ICGi003-A Stem Cell Res, 2020-08-03;48(0):101938. 2020-08-03 [PMID: 32795928] (ICC, Human)
• K Takahashi, D Jeong, S Wang, M Narita, X Jin, M Iwasaki, SD Perli, BR Conklin, S Yamanaka Critical Roles of Translation Initiation and RNA Uridylation in Endogenous Retroviral Expression and Neural Differentiation in Pluripotent Stem Cells Cell Rep, 2020-06-02;31(9):107715. 2020-06-02 [PMID: 32492424] (ICC, Human)
• M Kamand, M Ilieva, SL Forsberg, M Thomassen, Å Fex Svenni, B Holst, M Meyer, TM Michel Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder Stem Cell Res, 2020-05-07;46(0):101834. 2020-05-07 [PMID: 32447258] (ICC, Human)
• P Pongpamorn, J Dahlmann, A Haase, CT Ebeling, S Merkert, G Göhring, N Lachmann, A Martens, A Haverich, U Martin, R Olmer Generation of three induced pluripotent stem cell lines (MHHi012-A, MHHi013-A, MHHi014-A) from a family with Loeys-Dietz syndrome carrying a heterozygous p.M253I (c.759G>A) mutation in the TGFBR1 gene Stem Cell Res, 2020-02-04;43(0):101707. 2020-02-04 [PMID: 32062130] (Flow Cytometry, ICC, Human)
• NV Fuchs, M Schieck, M Neuenkirch, C Tondera, H Schmitz, L Wendeburg, D Steinemann, C Elpers, F Rutsch, R König Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Gouti�res syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1) Stem Cell Res, 2020-01-09;43(0):101697. 2020-01-09 [PMID: 32062129] (ICC, Human)
• K Haake, T Wüstefeld, S Merkert, D Lüttge, G Göhring, B Auber, U Baumann, N Lachmann Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis Stem Cell Res, 2020-01-17;43(0):101713. 2020-01-17 [PMID: 32000109] (ICC, Human)
• NV Fuchs, M Schieck, M Neuenkirch, C Tondera, H Schmitz, D Steinemann, G Göhring, R König Induced pluripotent stem cell line (PEIi003-A) derived from an apparently healthy male individual Stem Cell Res, 2019-12-04;42(0):101679. 2019-12-04 [PMID: 31837633] (ICC, Human)
• E Rodríguez-, E Díaz-Guerr, C Rodríguez, F Arenas, M Orera, J Kulisevsky, R Moratalla, C Vicario A collection of three integration-free iPSCs derived from old male and female healthy subjects Stem Cell Res, 2019-11-23;42(0):101663. 2019-11-23 [PMID: 31794941] (ICC, Human)
• E Díaz-Guerr, E Rodríguez-, EP Moreno-Jim, I de Rojas, C Rodríguez, M Orera, I Hernández, A Ruiz, C Vicario An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer's disease patient with the APOE-epsilon4/epsilon4 alleles Stem Cell Res, 2019-10-08;41(0):101588. 2019-10-08 [PMID: 31698192] (ICC, Human)
• NV Fuchs, M Schieck, M Neuenkirch, C Tondera, H Schmitz, V des Portes, D Germanaud, D Steinemann, G Göhring, R König Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A) Stem Cell Res, 2019-10-15;41(0):101592. 2019-10-15 [PMID: 31698189] (ICC, Human)
• T Hiramoto, M Tahara, J Liao, Y Soda, Y Miura, R Kurita, H Hamana, K Inoue, H Kohara, S Miyamoto, Y Hijikata, S Okano, Y Yamaguchi, Y Oda, K Ichiyanagi, H Toh, H Sasaki, H Kishi, A Ryo, A Muraguchi, M Takeda, K Tani Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells Mol. Ther., 2019-09-12;28(1):129-141. 2019-09-12 [PMID: 31677955] (IHC, Human)
• E Díaz-Guerr, MA Oria-Murie, EP Moreno-Jim, I de Rojasb, C Rodríguez, E Rodríguez-, M Orera, I Hernándezb, A Ruizb, C Vicario Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation Stem Cell Res, 2019-09-10;40(0):101574. 2019-09-10 [PMID: 31627126] (Differentiation, Differentiation, Human)
• E Rodríguez-, C Rodríguez, E Díaz-Guerr, F Arenas, M Araúzo-Bra, M Orera, J Kulisevsky, R Moratalla, C Vicario Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene Stem Cell Res, 2019-09-12;40(0):101578. 2019-09-12 [PMID: 31539859] (ICC, Human)
• XH Ma, S Wang, SY Liu, K Chen, ZY Wu, DF Li, YT Mi, LB Hu, ZW Chen, XM Zhao Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma World J. Gastroenterol., 2019-06-28;25(24):3030-3043. 2019-06-28 [PMID: 31293339] (Flow Cytometry, Mouse)
• E Rodríguez-, E Díaz-Guerr, C Rodríguez, P Fernández, F Arenas, M Araúzo-Bra, M Orera, J Kulisevsky, R Moratalla, C Vicario A collection of integration-free iPSCs derived from Parkinson's disease patients carrying mutations in the GBA1 gene Stem Cell Res, 2019-06-06;38(0):101482. 2019-06-06 [PMID: 31203165] (ICC, Human)
• B de la Cerd, A Díez-Llore, B Ponte, L Vallés-Sai, SM Calado, E Rodríguez-, AB Garcia-Del, M Moya-Molin, SS Bhattachar, FJ Díaz-Corra Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene Stem Cell Res, 2019-03-20;36(0):101426. 2019-03-20 [PMID: 30921587] (IHC, Xenograft)
• A Castelli, L Susani, C Menale, S Muggeo, E Caldana, D Strina, B Cassani, C Recordati, E Scanziani, F Ficara, A Villa, P Vezzoni, M Paulis Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells Stem Cells, 2019-04-02;0(0):. 2019-04-02 [PMID: 30895693] (ICC, Mouse)
• X Gao, JJ Yourick, RL Sprando Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel Stem Cell Res, 2018-07-27;31(0):193-196. 2018-07-27 [PMID: 30099336] (ICC, Human)
• J Higelin, A Catanese, LL Semelink-S, S Oeztuerk, AK Lutz, J Bausinger, G Barbi, G Speit, PM Andersen, AC Ludolph, M Demestre, TM Boeckers NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons Stem Cell Res, 2018-06-12;30(0):150-162. 2018-06-12 [PMID: 29929116] (ICC, Human)
• A Bolinches-, D Lukovic, AA Castro, M León, K Kamenarova, R Kaneva, P Jendelova, F Blanco-Kel, C Ayuso, M Cortón, S Erceg Generation of a human iPSC line from a patient with congenital glaucoma caused by mutation in CYP1B1 gene Stem Cell Res, 2018-01-04;28(0):96-99. 2018-01-04 [PMID: 29453128] (Flow Cytometry, ICC, Human)
• Y Tanaka, T Sone, N Higurashi, T Sakuma, S Suzuki, M Ishikawa, T Yamamoto, J Mitsui, H Tsuji, H Okano, S Hirose Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene Stem Cell Res, 2018-02-02;28(0):100-104. 2018-02-02 [PMID: 29453127] (ICC, Human)
• J Zhang, H Cao, J Xie, C Fan, Y Xie, X He, M Liao, S Zhang, H Wang The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation Cell Death Dis, 2018-02-14;9(2):224. 2018-02-14 [PMID: 29445086] (ICC, Mouse)
• S Merkert, C Bednarski, G Göhring, T Cathomen, U Martin Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN Stem Cell Res, 2017-07-11;23(0):95-97. 2017-07-11 [PMID: 28925369] (ICC, Human)
• A Schmidt, TV Woedtke, J Stenzel, T Lindner, S Polei, B Vollmar, S Bekeschus One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet Int J Mol Sci, 2017-04-19;18(4):. 2017-04-19 [PMID: 28422070] (IHC, Mouse)
• Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease Sci Rep, 2016-09-23;6(0):32382. 2016-09-23 [PMID: 27660926] (IHC, Human)
• Kawaguchi T, Tsukiyama T, Kimura K, Matsuyama S, Minami N, Yamada M, Imai H Generation of Naive Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. PLoS ONE, 2015-08-19;10(8):e0135403. 2015-08-19 [PMID: 26287611] (IHC, Bovine)
• Takenaka C, Miyajima H, Yoda Y, Imazato H, Yamamoto T, Gomi S, Ohshima Y, Kagawa K, Sasaki T, Kawamata S Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE, 2015-06-26;10(6):e0129855. 2015-06-26 [PMID: 26115194] (IHC, Human)
• Nguyen L, Robinton D, Seligson M, Wu L, Li L, Rakheja D, Comerford S, Ramezani S, Sun X, Parikh M, Yang E, Powers J, Shinoda G, Shah S, Hammer R, Daley G, Zhu H Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell, 2014-08-11;26(2):248-61. 2014-08-11 [PMID: 25117712] (IHC-Fr, Mouse)
• Ohnuma , Kiyoshi, Fujiki , Ayaka, Yanagihara , Kana, Tachikawa , Saoko, Hayashi , Yohei, Ito , Yuzuru, Onuma , Yasuko, Chan , Techuan, Michiue , Tatsuo, Furue , Miho K, Asashima , Makoto Enzyme-free passage of human pluripotent stem cells by controlling divalent cations. Sci Rep, 2014-04-11;4(0):4646. 2014-04-11 [PMID: 24721898] (IHC, Human)
• Yamasaki S, Taguchi Y, Shimamoto A, Mukasa H, Tahara H, Okamoto T Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-Beta1 regulation of pluripotency. PLoS ONE, 2014-01-29;9(1):e87151. 2014-01-29 [PMID: 24489856] (ICC, Human)
• Bershteyn , Marina, Hayashi , Yohei, Desachy , Guillaum, Hsiao , Edward C, Sami , Salma, Tsang , Kathryn, Weiss , Lauren A, Kriegstein , Arnold R, Yamanaka , Shinya, Wynshaw-Boris , Anthony Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature, 2014-01-12;507(7490):99-103. 2014-01-12 [PMID: 24413397] (ICC, Human)
• Yamamizu K, Piao Y, Sharov A, Zsiros V, Yu H, Nakazawa K, Schlessinger D, Ko M Identification of transcription factors for lineage-specific ESC differentiation. Stem Cell Reports, 2013-11-27;1(6):545-59. 2013-11-27 [PMID: 24371809] (ICC, Mouse)
• Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y, Nabetani A, Ishikawa F, Arai Y, Hirose N, Okano H, Suzuki N Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS ONE, 2012-07-25;7(7):e41572. 2012-07-25 [PMID: 22848530] (ICC, Human)
• Jeon , Kilsoo, Lim , Hyejin, Kim , Jung-Hyu, Thuan , Nguyen V, Park , Seung Hw, Lim , Yu-Mi, Choi , Hye-Yeon, Lee , Eung-Ryo, Kim , Jin-Hoi, Lee , Myung-Sh, Cho , Ssang-Go Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev, 2012-06-01;21(14):2642-55. 2012-06-01 [PMID: 22512788] (ICC, Mouse)
• Li Z, Yang CS, Nakashima K, Rana TM Small RNA-mediated regulation of iPS cell generation. EMBO J., 2011-02-01;30(5):823-34. 2011-02-01 [PMID: 21285944] (ICC, Mouse)
• Oda Y, Yoshimura Y, Ohnishi H Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem., 2010-07-01;285(38):29270-8. 2010-07-01 [PMID: 20595386] (ICC, Human)
• Takenaka C, Nishishita N, Takada N, Jakt LM, Kawamata S Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp. Hematol., 2009-11-14;38(2):154-62. 2009-11-14 [PMID: 19922768] (ICC, Human)
• Rountree CB, Ding W, He L, Stiles B Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells, 2009-02-01;27(2):290-9. 2009-02-01 [PMID: 19008348] (IHC-P, Mouse)
• Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007-11-30;131(5):861-72. 2007-11-30 [PMID: 18035408] (ICC, Human)
• Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, Kahn M Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. U.S.A., 2007-03-19;104(13):5668-73. 2007-03-19 [PMID: 17372190] (ICC, Mouse)

Reviews for alpha-Fetoprotein/AFP Antibody (MAB1368) (3)

Average Rating: 4

(Based on 3 reviews)

We have 3 reviews tested in 2 species: Human, Pig.

reviewed by: Verified Customer ICC Pig 12/05/2016

Summary

• Application: Immunocytochemistry
• Sample Tested: pig trabecular meshwork
• Species: Pig

reviewed by: Verified Customer IF Human 02/04/2015

Summary

• Application: Immunofluorescence
• Sample Tested: See PMID 23658023
• Species: Human

reviewed by: Verified Customer IF Human 02/04/2015

Summary

• Application: Immunofluorescence
• Sample Tested: See PMID 22829291
• Species: Human

Bioinformatics

• Gene Symbol: AFP